10-K Filing

CDT EQUITY INC. CIK: 1896212 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001493152-24-014889`
Period End Date	20231231
Filing Date	20240416
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 154 Income Statement 140 Cash Flow Statement 200 Stockholders Equity 60

Balance Sheet 154 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	400.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.23M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	64.63M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	64.63M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	73.83M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	73.83M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$493.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$895.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$895.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$493.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	-	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$1.50M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$1.50M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$895.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$895.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$501.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$501.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	-	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	-	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	$5.00K	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible asset	`IntangibleAssetsNetExcludingGoodwill`	$5.00K	USD	Point-in-time
Prepaid Expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$1.49M	USD	Point-in-time
Prepaid Expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$1.49M	USD	Point-in-time
Prepaid Expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	-	USD	Point-in-time
Prepaid Expenses and other long-term assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$900.00K	USD	Point-in-time
Total assets	`Assets`	$900.00K	USD	Point-in-time
Total assets	`Assets`	$506.00K	USD	Point-in-time
Total assets	`Assets`	$506.00K	USD	Point-in-time
Total assets	`Assets`	$5.00K	USD	Point-in-time
Total assets	`Assets`	$5.00K	USD	Point-in-time
Total assets	`Assets`	$7.22M	USD	Point-in-time
Total assets	`Assets`	$7.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$215.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$215.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherLiabilitiesCurrent`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherLiabilitiesCurrent`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherLiabilitiesCurrent`	$200.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherLiabilitiesCurrent`	$200.00K	USD	Point-in-time
Accrued professional fees	`AccruedProfessionalFeesCurrent`	$361.00K	USD	Point-in-time
Accrued professional fees	`AccruedProfessionalFeesCurrent`	$361.00K	USD	Point-in-time
Accrued professional fees	`AccruedProfessionalFeesCurrent`	$2.25M	USD	Point-in-time
Accrued professional fees	`AccruedProfessionalFeesCurrent`	$2.25M	USD	Point-in-time
Accrued payroll	`EmployeeRelatedLiabilitiesCurrent`	$338.00K	USD	Point-in-time
Accrued payroll	`EmployeeRelatedLiabilitiesCurrent`	$338.00K	USD	Point-in-time
Accrued payroll	`EmployeeRelatedLiabilitiesCurrent`	$40.00K	USD	Point-in-time
Accrued payroll	`EmployeeRelatedLiabilitiesCurrent`	$40.00K	USD	Point-in-time
Option liability	`OptionLiability`	$1.42M	USD	Point-in-time
Option liability	`OptionLiability`	$1.42M	USD	Point-in-time
Option liability	`OptionLiability`	-	USD	Point-in-time
Option liability	`OptionLiability`	-	USD	Point-in-time
Convertible promissory note payable	`ConvertiblePromissoryNotePayable`	$800.00K	USD	Point-in-time
Convertible promissory note payable	`ConvertiblePromissoryNotePayable`	$800.00K	USD	Point-in-time
Convertible promissory note payable	`ConvertiblePromissoryNotePayable`	-	USD	Point-in-time
Convertible promissory note payable	`ConvertiblePromissoryNotePayable`	-	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$175.00K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$175.00K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$185.00K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$185.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.18M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Convertible notes payable, carried at fair value	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, carried at fair value	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, carried at fair value	`ConvertibleLongTermNotesPayable`	$1.83M	USD	Point-in-time
Convertible notes payable, carried at fair value	`ConvertibleLongTermNotesPayable`	$1.83M	USD	Point-in-time
Liability related to the sale of future revenue	`DeferredRevenueNoncurrent`	-	USD	Point-in-time
Liability related to the sale of future revenue	`DeferredRevenueNoncurrent`	-	USD	Point-in-time
Liability related to the sale of future revenue	`DeferredRevenueNoncurrent`	$4.08M	USD	Point-in-time
Liability related to the sale of future revenue	`DeferredRevenueNoncurrent`	$4.08M	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	$142.00K	USD	Point-in-time
Derivative warrant liability	`DerivativeLiabilitiesNoncurrent`	$142.00K	USD	Point-in-time
Deferred commission payable	`DeferredCommissionPayableNonCurrent`	$5.74M	USD	Point-in-time
Deferred commission payable	`DeferredCommissionPayableNonCurrent`	$5.74M	USD	Point-in-time
Deferred commission payable	`DeferredCommissionPayableNonCurrent`	-	USD	Point-in-time
Deferred commission payable	`DeferredCommissionPayableNonCurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$10.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.68M	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares and 400,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, 73,829,536 shares and 64,626,430 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares and 400,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, 73,829,536 shares and 64,626,430 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares and 400,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, 73,829,536 shares and 64,626,430 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Common stock, par value $0.0001; 250,000,000 shares and 400,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, 73,829,536 shares and 64,626,430 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares and nil shares authorized at December 31, 2023 and December 31, 2022, respectively; nil shares issued and outstanding at December 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares and nil shares authorized at December 31, 2023 and December 31, 2022, respectively; nil shares issued and outstanding at December 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares and nil shares authorized at December 31, 2023 and December 31, 2022, respectively; nil shares issued and outstanding at December 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001; 1,000,000 shares and nil shares authorized at December 31, 2023 and December 31, 2022, respectively; nil shares issued and outstanding at December 31, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.82M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.82M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.42M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-14.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.44M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$675.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$675.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$411.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$411.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-14.51M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-14.51M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-12.02M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-12.02M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-5.96M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-5.96M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$506.00K	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$506.00K	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$7.22M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$5.00K	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$900.00K	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$900.00K	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$7.22M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$5.00K	USD	Point-in-time

Income Statement 140 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$37.00K	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$37.00K	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$90.00K	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$90.00K	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.51M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.51M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.83M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.83M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.31M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.83M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.31M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.05M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.05M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$430.00K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$430.00K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.17M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.17M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.83M	USD	2 Qtrs
Funding expenses	`FundingExpenses`	$74.00K	USD	Annual
Funding expenses	`FundingExpenses`	$74.00K	USD	Annual
Funding expenses	`FundingExpenses`	-	USD	Annual
Funding expenses	`FundingExpenses`	-	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$3.16M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$2.83M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$2.83M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$2.83M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$3.16M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$5.26M	USD	Annual
Total operating costs and expenses	`OperatingExpenses`	$2.83M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$430.00K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$430.00K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.31M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.31M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$5.26M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.16M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.31M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.31M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.83M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.83M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.83M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.16M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.51M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.51M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.26M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-5.26M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-430.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-430.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.83M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$4.92M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$4.92M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.73M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.73M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$15.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$15.00K	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	-	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	-	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-211.00K	USD	Annual
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-211.00K	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$4.73M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$4.73M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-1.73M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-1.73M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-3.78M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-4.89M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-4.89M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-3.78M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-535.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-535.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Less: Change in fair value and income impact of option liabilities	`ChangeInFairValueAndIncomeImpactOfOptionLiabilities`	$5.52M	USD	Annual
Less: Change in fair value and income impact of option liabilities	`ChangeInFairValueAndIncomeImpactOfOptionLiabilities`	$5.52M	USD	Annual
Less: Change in fair value and income impact of option liabilities	`ChangeInFairValueAndIncomeImpactOfOptionLiabilities`	-	USD	Annual
Less: Change in fair value and income impact of option liabilities	`ChangeInFairValueAndIncomeImpactOfOptionLiabilities`	-	USD	Annual
Net income (loss) - diluted	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-4.89M	USD	Annual
Net income (loss) - diluted	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-4.89M	USD	Annual
Net income (loss) - diluted	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-6.06M	USD	Annual
Net income (loss) - diluted	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-6.06M	USD	Annual
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.01	USD	Annual
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.01	USD	Annual
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.13	USD	Annual
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.01	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-1.89K	USD	2 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.01	USD	3 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-1.89K	USD	2 Qtrs
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-835.00	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-1.05K	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-1.05K	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-0.13	USD	Annual
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$-835.00	USD	1 Quarter
Basic earnings/(net loss) per share	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-835.00	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.06	USD	3 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-1.89K	USD	2 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-1.89K	USD	2 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.06	USD	3 Qtrs
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-835.00	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.09	USD	Annual
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-1.05K	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.13	USD	Annual
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.13	USD	Annual
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-0.09	USD	Annual
Diluted earnings/(net loss) per share	`EarningsPerShareDiluted`	$-1.05K	USD	1 Quarter
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	37.45M	shares	Annual
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	37.45M	shares	Annual
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	66.97M	shares	Annual
Basic weighted-average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	66.97M	shares	Annual
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	67.89M	shares	Annual
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	67.89M	shares	Annual
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.45M	shares	Annual
Diluted weighted-average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.45M	shares	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$753.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$753.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-264.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-264.00K	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-744.00K	USD	3 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-1.94M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-1.94M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.49M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-2.49M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-744.00K	USD	3 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-4.13M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-4.42M	USD	2 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-799.00K	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-799.00K	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.23M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.23M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-4.42M	USD	2 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-4.13M	USD	Annual

Cash Flow Statement 200 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-535.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.89M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.89M	USD	Annual
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-535.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Gain on investment in equity securities	`GainLossOnInvestments`	-	USD	Annual
Gain on investment in equity securities	`GainLossOnInvestments`	-	USD	Annual
Gain on investment in equity securities	`GainLossOnInvestments`	$-129.00K	USD	Annual
Gain on investment in equity securities	`GainLossOnInvestments`	$-129.00K	USD	Annual
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	$-1.30M	USD	Annual
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	$-1.30M	USD	Annual
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	$1.28M	USD	Annual
Gain on change in fair value of Cizzle option	`GainLossOnChangeInFairValueOfCizzleOption`	$1.28M	USD	Annual
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	-	USD	Annual
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	-	USD	Annual
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	$970.00K	USD	Annual
Gain on change in fair value of Vela option	`GainOnChangeInFairValueOfVelaOption`	$970.00K	USD	Annual
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	$987.00K	USD	Annual
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	$987.00K	USD	Annual
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	-	USD	Annual
Loss on issuance of Vela option	`LossOnIssuanceOfVelaOption`	-	USD	Annual
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	-	USD	Annual
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	-	USD	Annual
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	$39.00K	USD	Annual
Unrealized foreign exchange gain	`ForeignCurrencyTransactionGainLossUnrealizedAfterTax`	$39.00K	USD	Annual
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	$240.00K	USD	Annual
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	$240.00K	USD	Annual
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	$-331.00K	USD	Annual
Change in reserve for related party uncollectible loan	`ChangesInForeignCurrencyTransactionUnrealized`	$-331.00K	USD	Annual
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	$12.00K	USD	Annual
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	$12.00K	USD	Annual
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	-	USD	Annual
Loss on related party loan forgiveness	`LossOnRelatedPartyLoanForgiveness`	-	USD	Annual
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	$426.00K	USD	Annual
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	$426.00K	USD	Annual
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	$265.00K	USD	Annual
Loss on change in fair value of convertible notes payable	`LossOnChangeInFairValueOfConvertibleNotesPayable`	$265.00K	USD	Annual
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	-	USD	Annual
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	-	USD	Annual
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	$4.25M	USD	Annual
Non-cash reduction of deferred income upon exercise of option liability	`NoncashReductionOfDeferredIncomeUponExerciseOfOptionLiability`	$4.25M	USD	Annual
Gain on warrant remeasurement	`GainOnWarrantRemeasurement`	-	USD	Annual
Gain on warrant remeasurement	`GainOnWarrantRemeasurement`	-	USD	Annual
Gain on warrant remeasurement	`GainOnWarrantRemeasurement`	$81.00K	USD	Annual
Gain on warrant remeasurement	`GainOnWarrantRemeasurement`	$81.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	-	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$199.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$199.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	-	USD	Annual
Non-cash interest expense	`NoncashInterestExpense`	-	USD	Annual
Non-cash interest expense	`NoncashInterestExpense`	-	USD	Annual
Non-cash interest expense	`NoncashInterestExpense`	$87.00K	USD	Annual
Non-cash interest expense	`NoncashInterestExpense`	$87.00K	USD	Annual
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	-	USD	Annual
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	$479.00K	USD	Annual
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	$479.00K	USD	Annual
Amortization of financed Directors and Officers insurance	`AdjustmentForAmortization`	-	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	-	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	-	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.44M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.44M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$895.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$895.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$990.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$990.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$493.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$493.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	-	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	-	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$215.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$215.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities`	$1.75M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities`	$1.75M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities`	$-601.00K	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities`	$-601.00K	USD	Annual
Intangible assets	`IncreaseDecreaseInIntangibleAssetsCurrent`	$5.00K	USD	Annual
Intangible assets	`IncreaseDecreaseInIntangibleAssetsCurrent`	$5.00K	USD	Annual
Intangible assets	`IncreaseDecreaseInIntangibleAssetsCurrent`	$-5.00K	USD	Annual
Intangible assets	`IncreaseDecreaseInIntangibleAssetsCurrent`	$-5.00K	USD	Annual
Net cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.27M	USD	Annual
Net cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.72M	USD	Annual
Net cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.72M	USD	Annual
Net cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.27M	USD	Annual
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	$357.00K	USD	Annual
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	$357.00K	USD	Annual
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	$331.00K	USD	Annual
Issuance of loan - related party	`PaymentsToFundLongtermLoansToRelatedParties`	$331.00K	USD	Annual
Proceeds from issuance of option	`ProceedsFromIssuanceOfOption`	$148.00K	USD	Annual
Proceeds from issuance of option	`ProceedsFromIssuanceOfOption`	$148.00K	USD	Annual
Proceeds from issuance of option	`ProceedsFromIssuanceOfOption`	$497.00K	USD	Annual
Proceeds from issuance of option	`ProceedsFromIssuanceOfOption`	$497.00K	USD	Annual
Proceeds from loan repayment - related party	`ProceedsFromLoanRepaymentRelatedParty`	-	USD	Annual
Proceeds from loan repayment - related party	`ProceedsFromLoanRepaymentRelatedParty`	-	USD	Annual
Proceeds from loan repayment - related party	`ProceedsFromLoanRepaymentRelatedParty`	$585.00K	USD	Annual
Proceeds from loan repayment - related party	`ProceedsFromLoanRepaymentRelatedParty`	$585.00K	USD	Annual
Net cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$725.00K	USD	Annual
Net cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$725.00K	USD	Annual
Net cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-183.00K	USD	Annual
Net cash flows from investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-183.00K	USD	Annual
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	-	USD	Annual
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	-	USD	Annual
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	$8.49M	USD	Annual
Proceeds from Merger and related PIPE Financing, net of transaction costs	`ProceedsFromMergerAndRelatedPipeFinancingNetOfTransactionCosts`	$8.49M	USD	Annual
Proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	$179.00K	USD	Annual
Proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	$179.00K	USD	Annual
Proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from the issuance of notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	$150.00K	USD	Annual
Capital contribution - related party	`ProceedsFromIssuanceOfCommonStock`	$150.00K	USD	Annual
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	-	USD	Annual
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	-	USD	Annual
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	$928.00K	USD	Annual
Proceeds from issuance of convertible notes payable, carried at fair value	`ProceedsFromIssuanceOfConvertibleNotesPayableCarriedAtFairValue`	$928.00K	USD	Annual
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	$2.29M	USD	Annual
Proceeds from issuance of convertible promissory note payable, carried at cost	`ProceedsFromConvertibleDebt`	$2.29M	USD	Annual
Proceeds from sale of equity securities	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Proceeds from sale of equity securities	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Proceeds from sale of equity securities	`ProceedsFromIssuanceOrSaleOfEquity`	$1.34M	USD	Annual
Proceeds from sale of equity securities	`ProceedsFromIssuanceOrSaleOfEquity`	$1.34M	USD	Annual
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.93M	USD	Annual
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.93M	USD	Annual
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.45M	USD	Annual
Net cash flows from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.45M	USD	Annual
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.93M	USD	Annual
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.93M	USD	Annual
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.00K	USD	Annual
Net change in cash and cash equivalents before effect of exchange rate changes	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$299.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$299.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.00K	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.00K	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.23M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.23M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	-	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	-	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToCizzleBiotechnologyHoldingPlc`	$151.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToCizzleBiotechnologyHoldingPlc`	$151.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToCizzleBiotechnologyHoldingPlc`	-	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToCizzleBiotechnologyHoldingPlc`	-	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToVelaTechnologiesPlcUponExerciseOfOption`	-	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToVelaTechnologiesPlcUponExerciseOfOption`	-	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToVelaTechnologiesPlcUponExerciseOfOption`	$544.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC upon exercise of option	`IssuanceOfConduitPharmaceuticalsInc.CommonStockToVelaTechnologiesPlcUponExerciseOfOption`	$544.00K	USD	Annual
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConduitPharmaceuticalsLimitedConvertibleNotesForSharesOfConduitPharmaceuticalsInc.CommonStockInConnectionWithMerger`	-	USD	Annual
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConduitPharmaceuticalsLimitedConvertibleNotesForSharesOfConduitPharmaceuticalsInc.CommonStockInConnectionWithMerger`	$3.69M	USD	Annual
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConduitPharmaceuticalsLimitedConvertibleNotesForSharesOfConduitPharmaceuticalsInc.CommonStockInConnectionWithMerger`	$3.69M	USD	Annual
Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger	`ExchangeOfConduitPharmaceuticalsLimitedConvertibleNotesForSharesOfConduitPharmaceuticalsInc.CommonStockInConnectionWithMerger`	-	USD	Annual
Deferred Underwriting Costs	`DeferredUnderwritingCosts`	-	USD	Annual
Deferred Underwriting Costs	`DeferredUnderwritingCosts`	-	USD	Annual
Deferred Underwriting Costs	`DeferredUnderwritingCosts`	$5.74M	USD	Annual
Deferred Underwriting Costs	`DeferredUnderwritingCosts`	$5.74M	USD	Annual
Prepaid expense of directors and officers insurance paid out of PIPE financings proceeds in connection with the Merger	`PrepaidExpenseOfDirectorsAndOfficersInsurancePaidIncludedInApicInConnectionWithMerger`	-	USD	Annual
Prepaid expense of directors and officers insurance paid out of PIPE financings proceeds in connection with the Merger	`PrepaidExpenseOfDirectorsAndOfficersInsurancePaidIncludedInApicInConnectionWithMerger`	-	USD	Annual
Prepaid expense of directors and officers insurance paid out of PIPE financings proceeds in connection with the Merger	`PrepaidExpenseOfDirectorsAndOfficersInsurancePaidIncludedInApicInConnectionWithMerger`	$2.25M	USD	Annual
Prepaid expense of directors and officers insurance paid out of PIPE financings proceeds in connection with the Merger	`PrepaidExpenseOfDirectorsAndOfficersInsurancePaidIncludedInApicInConnectionWithMerger`	$2.25M	USD	Annual
Accumulated deficit assumed to APIC as a result of the business combination	`AccumulatedDeficitAssumedToApicAsResultOfBusinessCombination`	$6.12M	USD	Annual
Accumulated deficit assumed to APIC as a result of the business combination	`AccumulatedDeficitAssumedToApicAsResultOfBusinessCombination`	$6.12M	USD	Annual
Accumulated deficit assumed to APIC as a result of the business combination	`AccumulatedDeficitAssumedToApicAsResultOfBusinessCombination`	-	USD	Annual
Accumulated deficit assumed to APIC as a result of the business combination	`AccumulatedDeficitAssumedToApicAsResultOfBusinessCombination`	-	USD	Annual
Initial value of warrant liabilities issued in connection with PIPE Financing	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	$223.00K	USD	Annual
Initial value of warrant liabilities issued in connection with PIPE Financing	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	$223.00K	USD	Annual
Initial value of warrant liabilities issued in connection with PIPE Financing	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	-	USD	Annual
Initial value of warrant liabilities issued in connection with PIPE Financing	`InitialValueOfWarrantLiabilitiesIssuedInConnectionWithPipeFinancing`	-	USD	Annual
Non-Cash Assets Assumed in the Merger Financing	`NoncashAssetsAssumedInMergerFinancing`	$91.00K	USD	Annual
Non-Cash Assets Assumed in the Merger Financing	`NoncashAssetsAssumedInMergerFinancing`	$91.00K	USD	Annual
Non-Cash Liabilities Assumed in the Merger Financing	`NoncashLiabilitiesAssumedInMergerFinancing`	$124.00K	USD	Annual
Non-Cash Liabilities Assumed in the Merger Financing	`NoncashLiabilitiesAssumedInMergerFinancing`	$124.00K	USD	Annual
Fair value of shares received and receivable related to the sale of future revenue	`FairValueOfSharesReceivedAndReceivableRelatedToSaleOfFutureRevenue`	$1.47M	USD	Annual
Fair value of shares received and receivable related to the sale of future revenue	`FairValueOfSharesReceivedAndReceivableRelatedToSaleOfFutureRevenue`	$1.47M	USD	Annual
Fair value of shares received and receivable related to the sale of future revenue	`FairValueOfSharesReceivedAndReceivableRelatedToSaleOfFutureRevenue`	-	USD	Annual
Fair value of shares received and receivable related to the sale of future revenue	`FairValueOfSharesReceivedAndReceivableRelatedToSaleOfFutureRevenue`	-	USD	Annual
Cash paid for interest	`CashPaidForInterest`	$124.00K	USD	Annual
Cash paid for interest	`CashPaidForInterest`	-	USD	Annual
Cash paid for interest	`CashPaidForInterest`	-	USD	Annual
Cash paid for interest	`CashPaidForInterest`	$124.00K	USD	Annual

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-14.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$-14.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$-12.02M	USD	Point-in-time
Balance	`StockholdersEquity`	$-12.02M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.96M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.96M	USD	Point-in-time
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$753.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$753.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-264.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-264.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.89M	USD	Annual
Net loss	`NetIncomeLoss`	$-535.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-535.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.67M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-780.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$2.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.89M	USD	Annual
Reclassification of additional paid-in-capital	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	Annual
Reclassification of additional paid-in-capital	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 3)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.69M	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date (Note 3)	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$3.69M	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	373,570.00	shares	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	373,570.00	shares	Annual
Issuance of common stock upon conversion of MURF Class A & Class B common stock in connection with merger (Note 3)	`StockIssuedDuringPeriodValueIssuanceOfCommonStockUponConversionOfCommonStockInConnectionWithMerge`	$15.22M	USD	Annual
Issuance of common stock upon conversion of MURF Class A & Class B common stock in connection with merger (Note 3)	`StockIssuedDuringPeriodValueIssuanceOfCommonStockUponConversionOfCommonStockInConnectionWithMerge`	$15.22M	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 3)	`StockIssuedDuringPeriodValueNewIssues`	$19.78M	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock in connection with PIPE Financing (Note 3)	`StockIssuedDuringPeriodValueNewIssues`	$19.78M	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC	`StockIssuedDuringPeriodValuePurchaseOfRevenue`	$151.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC	`StockIssuedDuringPeriodValuePurchaseOfRevenue`	$151.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC	`StockIssuedDuringPeriodValuePurchasesOfRevenue`	$544.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC	`StockIssuedDuringPeriodValuePurchasesOfRevenue`	$544.00K	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 3)	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	Annual
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the Merger (Note 3)	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	Annual
Reduction of excise tax liability associated with the Merger (Note 3)	`AdjustmentsToAdditionalPaidInCapitalReductionOfExciseTaxLiabilityAssociatedWithMerger`	$1.14M	USD	Annual
Reduction of excise tax liability associated with the Merger (Note 3)	`AdjustmentsToAdditionalPaidInCapitalReductionOfExciseTaxLiabilityAssociatedWithMerger`	$1.14M	USD	Annual
Capital contribution - related party	`AdjustmentsToAdditionalPaidInCapitalContributionRelatedParty`	$150.00K	USD	Annual
Capital contribution - related party	`AdjustmentsToAdditionalPaidInCapitalContributionRelatedParty`	$150.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$199.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$199.00K	USD	Annual
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-457.00K	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.96M	USD	Point-in-time
Balance	`StockholdersEquity`	$-5.96M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$-12.02M	USD	Point-in-time
Balance	`StockholdersEquity`	$-14.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$-14.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$-12.02M	USD	Point-in-time
Balance	`StockholdersEquity`	$-10.09M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.